XML 53 R43.htm IDEA: XBRL DOCUMENT
v3.22.1

License and Collaboration Agreements - Schedule of Payments Allocated to Performance Obligations (Details) - USD ($) $ in Thousands | Dec. 12, 2021 | Dec. 21, 2021
--- | --- | ---
Allocation of transaction price |  |
Deferred revenues as of 12/21/2021 |  | $ 165,086
Option payment for Domvanalimab | $ 275,000 |
Option payment for Etrumadenant | 250,000 |
Option payment for Quemliclustat | 200,000 |
Total transaction price allocated to performance obligations | 890,086 |
Allocation to performance obligations |  |
Domvanalimab license | 328,838 |
Etrumadenant license and R&D activities | 218,722 |
Quemliclustat license and R&D activities | 175,618 |
Domvanalimab R&D activities | 34,528 |
Zimberelimab R&D services | 11,243 |
Access rights related to the Company's research and development pipeline | 84,076 |
Material rights to option continuation periods | 37,061 |
Total | $ 890,086 |

X
- Definition Access rights related to the company's research and development pipeline. + References No definition available. + Details
Name: | rcus_AccessRightsRelatedToCompanySResearchAndDevelopmentPipeline
Namespace Prefix: | rcus_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Allocation of transaction price + References No definition available. + Details
Name: | rcus_AllocationOfTransactionPrice
Namespace Prefix: | rcus_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Allocation of transaction price. + References No definition available. + Details
Name: | rcus_AllocationOfTransactionPriceAbstract
Namespace Prefix: | rcus_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Allocation to performance obligations. + References No definition available. + Details
Name: | rcus_AllocationToPerformanceObligations
Namespace Prefix: | rcus_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Deferred revenues at amendment closing date. + References No definition available. + Details
Name: | rcus_DeferredRevenuesAtAmendmentClosingDate
Namespace Prefix: | rcus_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Domvanalimab License + References No definition available. + Details
Name: | rcus_DomvanalimabLicense
Namespace Prefix: | rcus_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Domvanalimab research and development activities. + References No definition available. + Details
Name: | rcus_DomvanalimabResearchAndDevelopmentActivities
Namespace Prefix: | rcus_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Etrumadenant license and research and development activities. + References No definition available. + Details
Name: | rcus_EtrumadenantLicenseAndResearchAndDevelopmentActivities
Namespace Prefix: | rcus_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Material rights to option continuation periods. + References No definition available. + Details
Name: | rcus_MaterialRightsToOptionContinuationPeriods
Namespace Prefix: | rcus_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Option payment for Domvanalimab. + References No definition available. + Details
Name: | rcus_OptionPaymentForDomvanalimab
Namespace Prefix: | rcus_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Option Payment for Etrumadenant + References No definition available. + Details
Name: | rcus_OptionPaymentForEtrumadenant
Namespace Prefix: | rcus_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Option Payment for Quemliclustat. + References No definition available. + Details
Name: | rcus_OptionPaymentForQuemliclustat
Namespace Prefix: | rcus_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Quemliclustat license and research and development activities. + References No definition available. + Details
Name: | rcus_QuemliclustatLicenseAndResearchAndDevelopmentActivities
Namespace Prefix: | rcus_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Zimberelimab research and development services. + References No definition available. + Details
Name: | rcus_ZimberelimabResearchAndDevelopmentServices
Namespace Prefix: | rcus_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenuePerformanceObligationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration